EODData

MEMBERSHIP REGISTER LOG IN

FRA, BH3: PTC Therapeutics Inc.

09 Jul 2026
LAST:

76.78

CHANGE:
 0.22		OPEN:
76.78		HIGH:
76.78		ASK:
0.00		VOLUME:
0
CHG(%):
0.29		PREV:
77.00		LOW:
76.78		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Jul 2676.7876.7876.7876.780
08 Jul 2677.0077.0077.0077.000
07 Jul 2673.4273.4273.4273.420
06 Jul 2672.6672.6672.6672.660
03 Jul 2672.5272.5272.5272.520
02 Jul 2670.1470.1470.1470.14400
30 Jun 2670.9270.9270.9270.920
29 Jun 2673.9273.9273.9273.920
25 Jun 2672.0072.0072.0072.000
23 Jun 2668.5868.5868.5868.580

PROFILE

Name:PTC Therapeutics Inc.
About:PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:500 Warren Corporate Center Drive, Warren, NJ, United States, 07059
Website:https://www.ptcbio.com
ISIN:US69366J2006
LEI:549300UJLWOIWFDGB318

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:8.96 
Forward P/E:5.92 
PEG Ratio:-0.26 
Price to Sales:2.96 
Price to Book:-21.76 
Profit Margin:0.42 
Operating Margin:0.02 
Return on Assets:0.26 
Return on Equity:0.33 
Revenue:1.51B 
EBITDA:30.0M 
Shares:79.44M 
Market Cap:6.099B 

TECHNICAL INDICATORS

MA5:74.483.1%
MA10:72.795.5%
MA20:68.7011.8%
MA50:62.9622.0%
MA100:60.1927.6%
MA200:59.8428.3%
STO9:96.79 
STO14:98.46 
RSI14:73.02 
WPR14:-1.54 
MTM14:14.08
ROC14:0.22 
ATR:1.81 
Week High:77.000.3%
Week Low:70.149.5%
Month High:77.000.3%
Month Low:60.8028.3%
Year High:77.000.3%
Year Low:36.60109.8%
Volatility:29.12